Feasibility and Efficacy of Nurse-Driven Acute Stroke Care

J Stroke Cerebrovasc Dis. 2017 May;26(5):987-991. doi: 10.1016/j.jstrokecerebrovasdis.2016.11.007. Epub 2016 Dec 21.

Abstract

Background: Acute stroke care requires rapid assessment and intervention. Replacing traditional sequential algorithms in stroke care with parallel processing using telestroke consultation could be useful in the management of acute stroke patients. The purpose of this study was to assess the feasibility of a nurse-driven acute stroke protocol using a parallel processing model.

Methods: This is a prospective, nonrandomized, feasibility study of a quality improvement initiative. Stroke team members had a 1-month training phase, and then the protocol was implemented for 6 months and data were collected on a "run-sheet." The primary outcome of this study was to determine if a nurse-driven acute stroke protocol is feasible and assists in decreasing door to needle (intravenous tissue plasminogen activator [IV-tPA]) times.

Results: Of the 153 stroke patients seen during the protocol implementation phase, 57 were designated as "level 1" (symptom onset <4.5 hours) strokes requiring acute stroke management. Among these strokes, 78% were nurse-driven, and 75% of the telestroke encounters were also nurse-driven. The average door to computerized tomography time was significantly reduced in nurse-driven codes (38.9 minutes versus 24.4 minutes; P < .04).

Conclusions: The use of a nurse-driven protocol is feasible and effective. When used in conjunction with a telestroke specialist, it may be of value in improving patient outcomes by decreasing the time for door to decision for IV-tPA.

Keywords: Nursing; acute ischemic stroke; door to needle; systems of care.

MeSH terms

  • Critical Pathways
  • Delivery of Health Care, Integrated
  • Feasibility Studies
  • Fibrinolytic Agents / administration & dosage*
  • Humans
  • Infusions, Intravenous
  • Nurse's Role*
  • Nursing Staff, Hospital*
  • Patient Care Team
  • Process Assessment, Health Care*
  • Prospective Studies
  • Stroke / diagnostic imaging
  • Stroke / drug therapy*
  • Stroke / nursing*
  • Teleradiology
  • Thrombolytic Therapy*
  • Time Factors
  • Time-to-Treatment*
  • Tissue Plasminogen Activator / administration & dosage*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator